Introduction
PTC Therapeutics (PTCT) is a pharmaceutical company with expertise in Ribonucleic acid biology. The company has strategic collaborations with Roche and SMA Foundation for spinal muscular atrophy research. Welcome Trust has provided grants to the company for research in tumor stem cells area as well as life threatening infections caused by drug resistant bacteria.
Pipeline
PTC Therapeutics has a pipeline of in-house drugs such as Ataluren (Translarna), PTC596 and RG7916 and recently purchased the Emflaza drug from Marathon Pharmaceuticals.
